List of insiders holdings for Voyager Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | NEUROCRINE BIOSCIENCES INC 10% Owner |
2023-02-24 06:15:52 | 8,575,316 0 |
8,575,316 | Form 13D |
| 2 | EcoR1 Capital LLC 10% Owner |
2024-11-14 18:13:11 | 5,617,719 0 |
5,617,719 | Form 13G |
| 3 | Hadley Harbor Master Investors (Cayman) L.P. 10% Owner |
2015-11-18 21:03:20 | 470,588 0 |
470,588 | Form 4 |
| 4 | Sandrock Alfred President and CEO |
2025-04-04 16:08:51 | 430,931 0 |
430,931 | Form 4 |
| 5 | Henderson Jane Sr. V.P. & CFO, Corp. Dev. |
2018-03-26 16:02:25 | 342,368 0 |
342,368 | Form 4 |
| 6 | Turenne Andre President & CEO |
2021-03-23 16:10:57 | 322,375 0 |
322,375 | Form 4 |
| 7 | Swartz Robin COO & CBO |
2025-02-24 16:19:33 | 312,147 0 |
312,147 | Form 4 |
| 8 | Jorgensen Nathan D. Chief Financial Officer |
2025-02-24 16:15:51 | 234,500 0 |
234,500 | Form 4 |
| 9 | Carter Todd Alfred Chief Scientific Officer |
2025-02-24 16:21:45 | 215,718 0 |
215,718 | Form 4 |
| 10 | Sah Dinah Ph.D. Chief Scientific Officer |
2019-01-17 20:51:14 | 213,688 0 |
213,688 | Form 4 |
| 11 | Fahey Sandell Jacquelyn Chief Legal Officer |
2025-02-24 16:18:00 | 206,143 0 |
206,143 | Form 4 |
| 12 | Third Rock Ventures III L.P. Third Rock Ventures GP III L.P. TRV GP III LLC STARR KEVIN P TEPPER ROBERT I 10% Owner |
2024-02-14 16:19:07 | 186,423 0 |
186,423 | Form 13G |
| 13 | Third Rock Ventures III L.P. Third Rock Ventures GP III L.P. TRV GP III LLC TEPPER ROBERT I 10% Owner |
2024-02-14 16:19:07 | 186,423 0 |
186,423 | Form 13G |
| 14 | PFREUNDSCHUH PETER P. Chief Financial Officer |
2024-02-22 16:32:59 | 175,669 0 |
175,669 | Form 4 |
| 15 | Ferguson Toby Chief Medical Officer |
2025-04-04 16:10:01 | 157,914 0 |
157,914 | Form 4 |
| 16 | Khwaja Omar See remarks |
2021-05-25 16:31:13 | 120,509 0 |
120,509 | Form 4 |
| 17 | Dorval Allison Chief Financial Officer |
2021-03-23 16:10:28 | 109,894 0 |
109,894 | Form 4 |
| 18 | Goater Jeff Chief Financial Officer |
2016-02-02 16:03:30 | 105,000 0 |
105,000 | Form 4 |
| 19 | Hesslein Robert W. Senior VP & General Counsel |
2023-03-22 16:47:41 | 102,200 0 |
102,200 | Form 4 |
| 20 | Burek Julie VP, Finance |
2022-03-23 18:36:44 | 52,458 0 |
52,458 | Form 4 |
| 21 | Ottmer Matthew P. Chief Operating Officer |
2020-01-29 17:26:53 | 26,276 0 |
26,276 | Form 4 |
| 22 | Colon Grace Director |
2024-06-07 16:15:13 | 24,000 0 |
24,000 | Form 4 |
| 23 | GERAGHTY JAMES A Director |
2024-06-07 16:15:45 | 24,000 0 |
24,000 | Form 4 |
| 24 | Higgins Michael J Director |
2024-06-07 16:16:51 | 24,000 0 |
24,000 | Form 4 |
| 25 | Hyman Steven Director |
2024-06-07 16:17:50 | 24,000 0 |
24,000 | Form 4 |
| 26 | MACKEY CATHERINE J Director |
2024-06-07 16:19:25 | 24,000 0 |
24,000 | Form 4 |
| 27 | Onyia Jude Director |
2024-06-07 16:20:15 | 24,000 0 |
24,000 | Form 4 |
| 28 | PIERCE GLENN Director |
2024-06-07 16:20:49 | 24,000 0 |
24,000 | Form 4 |
| 29 | SCANGOS GEORGE A Director |
2024-06-07 16:21:53 | 24,000 0 |
24,000 | Form 4 |
| 30 | Vitale Nancy Director |
2024-06-07 16:22:47 | 24,000 0 |
24,000 | Form 4 |
| 31 | KARSEN PERRY A Director |
2019-06-17 19:00:36 | 15,000 0 |
15,000 | Form 4 |
| 32 | PAUL STEVEN M Director |
2021-06-04 16:34:26 | 15,000 0 |
15,000 | Form 4 |
| 33 | DIXON WENDY L Director |
2020-06-05 16:16:36 | 15,000 0 |
15,000 | Form 4 |
| 34 | LEVIN MARK J Director 10% Owner |
2021-06-04 16:32:34 | 15,000 0 |
15,000 | Form 4 |
| 35 | Ravina Bernard Chief Medical Officer |
2018-04-12 16:01:23 | 0 0 |
0 | Form 4 |
| 36 | Sanofi Former 10% owner |
2019-02-11 08:41:02 | 0 0 |
0 | Form 13G |